The company is benefiting from a rebound in demand for nonurgent surgeries among older adults, who deferred those procedures during the Covid pandemic. Read this story
The company is benefiting from a rebound in demand for nonurgent surgeries among older adults, who deferred those procedures during the Covid pandemic. Read this story
More from CNBC | Business Biotechnology Biotech and Pharmaceuticals Pharmaceuticals Health care industry Johnson & Johnson Shockwave Medical Inc Kenvue Inc Earnings Breaking news Elevance Health Inc Humana Inc UnitedHealth Group Inc Amgen Inc Dividends business news cnbc Articles US: News Companies Business News Health & Science source:tagname:CNBC US Source NYSE:JNJ